Cardlytics Inc. (CDLX)
Cardlytics Statistics
Share Statistics
Cardlytics has 52.09M shares outstanding. The number of shares has increased by 15.22% in one year.
Shares Outstanding | 52.09M |
Shares Change (YoY) | 15.22% |
Shares Change (QoQ) | 1.97% |
Owned by Institutions (%) | 60.62% |
Shares Floating | 49.5M |
Failed to Deliver (FTD) Shares | 162.34K |
FTD / Avg. Volume | 14.86% |
Short Selling Information
The latest short interest is 7.86M, so 15.47% of the outstanding shares have been sold short.
Short Interest | 7.86M |
Short % of Shares Out | 15.47% |
Short % of Float | 16.23% |
Short Ratio (days to cover) | 8.6 |
Valuation Ratios
The PE ratio is -0.95 and the forward PE ratio is -6.54. Cardlytics's PEG ratio is -0.16.
PE Ratio | -0.95 |
Forward PE | -6.54 |
PS Ratio | 0.64 |
Forward PS | 0.3 |
PB Ratio | 2.56 |
P/FCF Ratio | -20.33 |
PEG Ratio | -0.16 |
Enterprise Valuation
Cardlytics Inc. has an Enterprise Value (EV) of 510.33M.
EV / Earnings | -2.7 |
EV / Sales | 1.83 |
EV / EBITDA | -3.35 |
EV / EBIT | -2.61 |
EV / FCF | -57.83 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 3.17.
Current Ratio | 1.19 |
Quick Ratio | 1.19 |
Debt / Equity | 3.17 |
Total Debt / Capitalization | 76 |
Cash Flow / Debt | -0.04 |
Interest Coverage | -21.96 |
Financial Efficiency
Return on equity (ROE) is -2.7% and return on capital (ROIC) is -67.03%.
Return on Equity (ROE) | -2.7% |
Return on Assets (ROA) | -0.48% |
Return on Capital (ROIC) | -67.03% |
Revenue Per Employee | $612,991.19 |
Profits Per Employee | $-416,969.16 |
Employee Count | 454 |
Asset Turnover | 0.71 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -87.3% in the last 52 weeks. The beta is 1.63, so Cardlytics's price volatility has been higher than the market average.
Beta | 1.63 |
52-Week Price Change | -87.3% |
50-Day Moving Average | 2.8 |
200-Day Moving Average | 4.39 |
Relative Strength Index (RSI) | 33.71 |
Average Volume (20 Days) | 1.09M |
Income Statement
In the last 12 months, Cardlytics had revenue of 278.3M and earned -189.3M in profits. Earnings per share was -3.91.
Revenue | 278.3M |
Gross Profit | 120.89M |
Operating Income | -195.5M |
Net Income | -189.3M |
EBITDA | -152.53M |
EBIT | -195.5M |
Earnings Per Share (EPS) | -3.91 |
Balance Sheet
The company has 65.59M in cash and 221.65M in debt, giving a net cash position of -156.06M.
Cash & Cash Equivalents | 65.59M |
Total Debt | 221.65M |
Net Cash | -156.06M |
Retained Earnings | -1.3B |
Total Assets | 392.71M |
Working Capital | 29.03M |
Cash Flow
In the last 12 months, operating cash flow was -8.82M and capital expenditures 0, giving a free cash flow of -8.82M.
Operating Cash Flow | -8.82M |
Capital Expenditures | 0 |
Free Cash Flow | -8.82M |
FCF Per Share | -0.18 |
Margins
Gross margin is 43.44%, with operating and profit margins of -70.25% and -68.02%.
Gross Margin | 43.44% |
Operating Margin | -70.25% |
Pretax Margin | -68.02% |
Profit Margin | -68.02% |
EBITDA Margin | -54.81% |
EBIT Margin | -70.25% |
FCF Margin | -3.17% |
Dividends & Yields
CDLX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -212.5% |
FCF Yield | -9.18% |
Analyst Forecast
The average price target for CDLX is $3.25, which is 76.6% higher than the current price. The consensus rating is "Hold".
Price Target | $3.25 |
Price Target Difference | 76.6% |
Analyst Consensus | Hold |
Analyst Count | 6 |
Scores
Altman Z-Score | -5.17 |
Piotroski F-Score | 3 |